Interactions of PGH Synthase Isozymes‐1 and ‐2 with NSAIDs a

There are two isozymes of prostaglandin endoperoxide (PGH) synthase (cyclooxygenase) called PGH synthase-1 and -2 or COX I and II. Both isozymes catalyze the same two reactions: oxygenation of arachidonate to yield PGG2 and reduction of PGG2 to PGH2. PGH synthase-1 is expressed constitutively and is found in most tissues. PGH synthase-2 is undetectable in most cells but can be induced in fibroblasts, endothelial cells, ovarian follicles, and macrophages by various mitogens, cytokines, and tumor promoters. PGH synthase-1 (PGHS-1) has been presumed to be the site of action of nonsteroidal antiinflammatory drugs (NSAIDs). However, the discovery of the second isozyme, PGH synthase-2 (PGHS-2), and its association with inflammation has suggested that this latter enzyme may be the therapeutic target of NSAIDs functioning in their antiinflammatory capacities. We have cloned cDNAs for murine PGHS-1 and PGHS-2, expressed these enzymes in cos-1 cells, and compared the relative sensitivities of the two isozymes to some common NSAIDs. Indomethacin, piroxicam, and sulindac sulfide were found to preferentially inhibit PGHS-1. Ibuprofen and meclofenamate inhibit both enzymes with comparable potencies. 6-Methoxy-2-naphthylacetic acid, the active metabolite of Relafen, inhibits murine PGHS-2 preferentially. Aspirin irreversibly inhibits PGHS-1, preventing this isozyme from forming PGH2 or any other oxygenated product; in contrast, aspirin treatment of PGHS-2 causes this enzyme to form 15-hydroxy-5c,8c,11c,13t-eicosatetraenoic acid (15-HETE) instead of PGH2. Our results indicate mouse PGHS-1 and PGHS-2 are pharmacologically distinct. Thus, it should be possible to develop agents highly selective for each PGHS isozyme. PGHS-2 is not expressed in stomach but is increased by inflammatory cytokines in cells such as macrophages. Thus, a selective inhibitor of PGHS-2 could be an antiinflammatory agent but without being ulcerogenic.

[1]  David A Jones,et al.  Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. , 1993, The Journal of biological chemistry.

[2]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[3]  S. Reddy,et al.  Expression of the protein product of the prostaglandin synthase-2/TIS10 gene in mitogen-stimulated Swiss 3T3 cells. , 1993, The Journal of biological chemistry.

[4]  D. Dewitt,et al.  Expression of the murine prostaglandin (PGH) synthase-1 and PGH synthase-2 isozymes in cos-1 cells. , 1993, Journal of lipid mediators.

[5]  S. Hart,et al.  Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. , 1992, The Journal of biological chemistry.

[6]  C. McCall,et al.  Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. , 1992, Biochemical and biophysical research communications.

[7]  T. Hla,et al.  Human cyclooxygenase-2 cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Smith.  Prostanoid biosynthesis and mechanisms of action. , 1992, The American journal of physiology.

[9]  F. Chilton,et al.  Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. , 1992, The Journal of biological chemistry.

[10]  M. Mattei,et al.  Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[11]  T. Shimokawa,et al.  Prostaglandin endoperoxide synthase. The aspirin acetylation region. , 1992, The Journal of biological chemistry.

[12]  J. Richards,et al.  Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. , 1992, The Journal of biological chemistry.

[13]  V. Winn,et al.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Seibert,et al.  Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H R Herschman,et al.  Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene. , 1992, The Journal of biological chemistry.

[16]  J. Richards,et al.  Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. , 1992, The Journal of biological chemistry.

[17]  H. Herschman,et al.  Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. , 1992, The Journal of biological chemistry.

[18]  D. Dewitt,et al.  Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences. , 1992, Archives of biochemistry and biophysics.

[19]  S. Yamamoto,et al.  cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1). , 1991, The Journal of biological chemistry.

[20]  B. Varnum,et al.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. , 1991, The Journal of biological chemistry.

[21]  G. FitzGerald,et al.  Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  D. Dewitt.  Prostaglandin endoperoxide synthase: regulation of enzyme expression. , 1991, Biochimica et biophysica acta.

[23]  T. Shimokawa,et al.  Essential histidines of prostaglandin endoperoxide synthase. His-309 is involved in heme binding. , 1991, The Journal of biological chemistry.

[24]  M. Dunn,et al.  Regulation of prostaglandin endoperoxide synthase gene expression in cultured rat mesangial cells: induction by serum via a protein kinase-C-dependent mechanism. , 1991, Molecular endocrinology.

[25]  T. Shimokawa,et al.  Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis. , 1990, The Journal of biological chemistry.

[26]  Stephan Gebel,et al.  Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.

[27]  T. Hla,et al.  Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. , 1990, The Journal of biological chemistry.

[28]  Eveline,et al.  The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases. , 1990, The Journal of biological chemistry.

[29]  C. Yokoyama,et al.  Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. , 1989, Biochemical and biophysical research communications.

[30]  H. Toh.  Prostaglandin endoperoxide synthase contains an EGF‐like domain , 1989, FEBS letters.

[31]  B. Setty,et al.  Time-dependent inhibition of platelet cyclooxygenase by indomethacin is slowly reversible. , 1986, Prostaglandins.

[32]  W. Lands,et al.  Stoichiometry and kinetics of the interaction of prostaglandin H synthase with anti-inflammatory agents. , 1985, The Journal of biological chemistry.

[33]  R. Haddock,et al.  Metabolism of nabumetone (BRL 14777) by various species including man. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[34]  W. K. Sonnenburg,et al.  Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta. , 1983, The Journal of clinical investigation.

[35]  J. Case,et al.  In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. , 1992, The Journal of clinical investigation.

[36]  W. Xie,et al.  Multiple Cyclooxygenases: Cloning of a Mitogen-Inducible Form , 1991 .

[37]  H. Herschman.  Primary response genes induced by growth factors and tumor promoters. , 1991, Annual review of biochemistry.

[38]  D. Dewitt,et al.  Serum induction and superinduction of PGG/H synthase mRNA levels in 3T3 fibroblasts. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[39]  大島 岳夫.  cAMP-dependent induction of fatty acid cyclooxygenase mRNA in mouse osteoblastic cells (MC3T3-E1) , 1991 .